M1090 Infliximab Therapy Significantly Reduces Subsequent Disease-Related Costs in Crohn's Disease Patients: A 2-Year Follow-Up Study

Autor: Sprakes, Michael B., Ford, Alexander C., Lisa, Warren, Greer, Dan, Jennings, Jason, Donnellan, Clare, Everett, Simon, Hamlin, John P.
Zdroj: In Gastroenterology 2009 136(5) Supplement 1:A
Databáze: ScienceDirect